Zacks Investment Research upgraded shares of Sensient Technologies (NYSE:SXT) from a hold rating to a buy rating in a report released on Thursday morning. Zacks Investment Research currently has $78.00 target price on the specialty chemicals company’s stock.
According to Zacks, “Sensient Technologies Corporation is a leading global manufacturer and marketer of colors, flavors and fragrances. Sensient employ advanced technologies to develop specialty food and beverage systems, cosmetic ingredients, pharmaceutical excipients, inkjet and specialty inks and colors, and other specialty and fine chemicals. Sensient uses advanced proprietary technologies to produce a broad range of innovative products. Sensient is a global developer, manufacturer and supplier of flavor and fragrance systems for the food, beverage, personal care and household-products industries. Sensient is a developer, manufacturer and supplier of colors for businesses worldwide. Sensient provides natural and synthetic color systems for use in foods, beverages and pharmaceuticals; colors and other ingredients for cosmetics, such as active ingredients, solubilizers and surface treated pigments; pharmaceutical excipients, such as colors, flavors and coatings; specialty inks; and technical colors for industrial applications. “
A number of other equities research analysts have also commented on SXT. TheStreet lowered Sensient Technologies from a b rating to a c+ rating in a research report on Thursday, February 8th. Gabelli upgraded Sensient Technologies from a hold rating to a buy rating and set a $94.00 price objective for the company in a research report on Monday, February 12th. Finally, Off Wall Street began coverage on Sensient Technologies in a research report on Monday, December 18th. They set a sell rating for the company. Two analysts have rated the stock with a sell rating and four have assigned a buy rating to the stock. Sensient Technologies presently has an average rating of Hold and an average price target of $87.58.
NYSE SXT traded down $0.27 during trading on Thursday, reaching $69.18. 38,315 shares of the company’s stock were exchanged, compared to its average volume of 343,788. Sensient Technologies has a fifty-two week low of $65.60 and a fifty-two week high of $84.98. The firm has a market capitalization of $3,011.25, a PE ratio of 20.21, a PEG ratio of 2.28 and a beta of 0.93. The company has a current ratio of 3.39, a quick ratio of 1.25 and a debt-to-equity ratio of 0.71.
Sensient Technologies (NYSE:SXT) last announced its quarterly earnings data on Thursday, February 8th. The specialty chemicals company reported $0.84 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.84. Sensient Technologies had a return on equity of 17.37% and a net margin of 6.58%. The firm had revenue of $328.87 million during the quarter. research analysts anticipate that Sensient Technologies will post 3.83 EPS for the current year.
In other news, Director Gebhardt Deborah Mckeithan purchased 1,000 shares of Sensient Technologies stock in a transaction dated Tuesday, February 20th. The stock was acquired at an average cost of $72.10 per share, for a total transaction of $72,100.00. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Hank Brown sold 2,000 shares of Sensient Technologies stock in a transaction dated Thursday, February 15th. The shares were sold at an average price of $71.78, for a total value of $143,560.00. The disclosure for this sale can be found here. 0.94% of the stock is owned by insiders.
Institutional investors have recently made changes to their positions in the company. Xact Kapitalforvaltning AB acquired a new stake in Sensient Technologies in the 4th quarter worth approximately $449,000. BRYN MAWR TRUST Co increased its position in Sensient Technologies by 5.0% in the 4th quarter. BRYN MAWR TRUST Co now owns 98,961 shares of the specialty chemicals company’s stock worth $7,239,000 after buying an additional 4,756 shares during the period. MetLife Investment Advisors LLC bought a new position in Sensient Technologies in the 4th quarter worth approximately $3,434,000. Vident Investment Advisory LLC increased its position in Sensient Technologies by 78.6% in the 4th quarter. Vident Investment Advisory LLC now owns 5,728 shares of the specialty chemicals company’s stock worth $419,000 after buying an additional 2,520 shares during the period. Finally, Dean Capital Management bought a new position in Sensient Technologies in the 4th quarter worth approximately $3,233,000. Institutional investors and hedge funds own 90.99% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Sensient Technologies (SXT) Upgraded by Zacks Investment Research to “Buy”” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another site, it was illegally stolen and republished in violation of international copyright & trademark law. The correct version of this article can be accessed at https://www.dispatchtribunal.com/2018/04/13/sensient-technologies-sxt-upgraded-by-zacks-investment-research-to-buy.html.
Sensient Technologies Company Profile
Sensient Technologies Corporation is a manufacturer and marketer of colors, flavors and fragrances. The Company uses technologies at facilities around the world to develop specialty food and beverage systems, cosmetic and pharmaceutical systems, specialty inks and colors, and other specialty and fine chemicals.
Get a free copy of the Zacks research report on Sensient Technologies (SXT)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sensient Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sensient Technologies and related companies with MarketBeat.com's FREE daily email newsletter.